Kakizaki S - Search Results

1

Favorable outcome of retreatment by direct-acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure.

Tojima H, Kakizaki S, Takakusagi S, Hoshino T, Naganuma A, Nagashima T, Namikawa M, Ueno T, Shimada Y, Hatanaka T, Takizawa D, Arai H, Sato K, Takagi H, Uraoka T. Tojima H, et al. Among authors: kakizaki s. Hepatol Res. 2020 Mar;50(3):303-312. doi: 10.1111/hepr.13462. Epub 2019 Dec 19. Hepatol Res. 2020. PMID: 31750974

2

[A case of tiopronin-induced prolonged intrahepatic cholestasis improved by steroid-pulse therapy].

Nada Y, Yamada T, Kakizaki S, Abe T, Ojima T, Matsumoto T, Saitoh S, Takagi H. Nada Y, et al. Among authors: kakizaki s. Nihon Shokakibyo Gakkai Zasshi. 1996 Mar;93(3):216-9. Nihon Shokakibyo Gakkai Zasshi. 1996. PMID: 8721120 Japanese. No abstract available.

3

Prediction of effect of interferon on chronic hepatitis C.

Takagi H, Takehara K, Shimoda R, Kakizaki S, Takayama H, Abe T, Yamada T, Hashimoto Y, Saitoh S, Matsumoto T, Kojima A, Takezawa J, Yuasa K, Moriguchi M, Sekiguchi T, Nagamine T, Mori M. Takagi H, et al. Among authors: kakizaki s. Dig Dis Sci. 1997 Nov;42(11):2270-6. doi: 10.1023/a:1018866717753. Dig Dis Sci. 1997. PMID: 9398805

4

Cardiac angiosarcoma responding to multidisciplinary treatment.

Kakizaki S, Takagi H, Hosaka Y. Kakizaki S, et al. Int J Cardiol. 1997 Dec 19;62(3):273-5. doi: 10.1016/s0167-5273(97)00259-3. Int J Cardiol. 1997. PMID: 9476688

5

An increase of circulating leptin in patients with liver cirrhosis.

Shimizu H, Kakizaki S, Tsuchiya T, Nagamine T, Takagi H, Takayama H, Kobayashi I, Mori M. Shimizu H, et al. Among authors: kakizaki s. Int J Obes Relat Metab Disord. 1998 Dec;22(12):1234-8. doi: 10.1038/sj.ijo.0800768. Int J Obes Relat Metab Disord. 1998. PMID: 9877260

6

HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.

Kakizaki S, Takagi H, Murakami M, Takayama H, Mori M. Kakizaki S, et al. J Hepatol. 1999 May;30(5):794-800. doi: 10.1016/s0168-8278(99)80131-7. J Hepatol. 1999. PMID: 10365804

7

[Autoimmune thyroid disease induced by interferon therapy].

Murakami M, Kakizaki S, Takayama H, Takagi H, Mori M. Murakami M, et al. Among authors: kakizaki s. Nihon Rinsho. 1999 Aug;57(8):1779-83. Nihon Rinsho. 1999. PMID: 10483250 Review. Japanese.

8

Faropenem enhances superoxide anion production by human neutrophils in vitro.

Sato K, Sato N, Shimizu H, Tsutiya T, Takahashi H, Kakizaki S, Takayama H, Takagi H, Mori M. Sato K, et al. Among authors: kakizaki s. J Antimicrob Chemother. 1999 Sep;44(3):337-41. doi: 10.1093/jac/44.3.337. J Antimicrob Chemother. 1999. PMID: 10511400

9

Iron enhances hepatitis C virus replication in cultured human hepatocytes.

Kakizaki S, Takagi H, Horiguchi N, Toyoda M, Takayama H, Nagamine T, Mori M, Kato N. Kakizaki S, et al. Liver. 2000 Apr;20(2):125-8. doi: 10.1034/j.1600-0676.2000.020002125.x. Liver. 2000. PMID: 10847480

10

Role of serum soluble Fas/soluble Fas ligand and TNF-alpha on response to interferon-alpha therapy in chronic hepatitis C.

Toyoda M, Kakizaki S, Horiguchi N, Sato K, Takayama H, Takagi H, Nagamine T, Mori M. Toyoda M, et al. Among authors: kakizaki s. Liver. 2000 Jul;20(4):305-11. doi: 10.1034/j.1600-0676.2000.020004305.x. Liver. 2000. PMID: 10959809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

376 results

Search Page

Filters